Is The Chemours Company (CC) a Buy, Sell, or Hold?
NYSE : CC
The Chemours Company — Analyst Ratings
$16.61 USD
-$0.5 (-2.92%)
- Volume
- 1.94M
- Average Volume
- 2.7M
- Market Capitalization
- $2.5B
- P/E Ratio
- -6.08
- Dividend Yield
- 2.11%
- Price Target
- $29.50
- Year High
- $28.67
- Year Low
- $10.44
- Day High
- —
- Day Low
- —
- Payout Ratio
- -$0.13
- Current Ratio
- $1.82
Analyst Consensus Summary
Consensus Rating
Strong Sell
20 Analysts
Rating Score
1/5
Recommendation Strength
Upside/Downside
-43.7%
vs Current Price
Price Target
$29.50
Average TargetPrice Target Range
Lowest Target
$17.00
-2.3% DOWNSIDE
Average Target
$29.50
Median Estimate
Highest Target
$30.00
-44.6% DOWNSIDEAnalyst Breakdown
Overall Consensus: Hold | Total Analysts: 20
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 9 | 10 | 1 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Morgan Stanley | Vincent Andrews | $21 | $24.45 | 2026-05-11 08:16 AM | -14.1% |
| Mizuho Securities | John Roberts | $30 | $27.93 | 2026-05-06 07:51 AM | 7.4% |
| Truist Financial | Peter Osterland | $30 | $26.48 | 2026-04-28 06:44 AM | 13.3% |
| RBC Capital | Arun Viswanathan | $26 | $22.86 | 2026-04-10 08:26 AM | 13.7% |
| Jefferies | Laurence Alexander | $17 | $18.155 | 2026-02-23 11:57 AM | -6.4% |